New FDA guidelines for use of Aduhelm – a step in chasing the rainbow?
Today Biogen announced the changes highlighted in yellow below in the prescribing information for Aduhelm, recently approved for treatment of Alzheimer’s disease. There were several problems with the FDA’s initial brand label authorizing use...
Recent Comments